Cellular and molecular gastroenterology and hepatology · 2026
Sirtuin 2 Contributes to Pancreatic Injury and Inflammation by Modulating Immediate Early Response 3-Mediated Ferroptosis in Acute Pancreatitis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ma Shi-Ya, Shen Zhao-Jian, Zhu Chong-Zhi, Shen Cui, Lu Zhong-Hua, Sun Yun, Yu Wei-Li
Аннотация
BACKGROUND & AIMS: Acute pancreatitis is a potentially life-threatening inflammatory disorder characterized by trypsin overactivation within acinar cells. Although sirtuin 2 is linked to inflammation, its precise role in acute pancreatitis remains poorly understood.
METHODS: Rats were pretreated with AGK2 a (sirtuin 2 inhibitor), Ferrostatin-1 (ferroptosis inhibitor), 1α,25-dihydroxyvitamin D3 (an immediate early response 3 inhibitor), adeno-associated virus-sirtuin 2, or adeno-associated virus-short hairpin-sirtuin 2 before L-arginine-induced acute pancreatitis. RNA sequencing was performed to identify potential downstream targets of sirtuin 2. In vitro, sirtuin 2 and immediate early response 3 expression was manipulated by small interfering RNA or overexpression plasmids. The effects on ferroptosis and inflammation were assessed using Western blot, quantitative polymerase chain reaction, immunofluorescence, and assays measuring reactive oxygen species, iron (II), mitochondrial membrane potential, and lipid peroxidation. Regulatory mechanisms among sirtuin 2, immediate early response 3, and ferroptosis were further investigated using co-immunoprecipitation and dual-luciferase assays.
RESULTS: AGK2 or ferrostatin-1 alone reduced pancreatic damage, inflammation, and ferroptosis, with combination therapy showing synergy. Sirtuin 2 or immediate early response 3 inhibition was protective, upregulating solute carrier family 7 member 11-glutathione peroxidase 4, reducing reactive oxygen species, iron (II), and lipid peroxides, and restoring mitochondrial function. Conversely, overexpression of sirtuin 2 or immediate early response 3 produced the opposite effects. AGK2 and 1α,25-dihydroxyvitamin D3 reversed damage from sirtuin 2 overexpression. Co-immunoprecipitation confirmed sirtuin 2 deacetylates and upregulates immediate early response 3. Luciferase assays showed immediate early response 3 transcriptionally represses solute carrier family 7 member 11. Clinically, serum sirtuin 2 and immediate early response 3 were elevated in patients with acute pancreatitis and correlated with disease severity and inflammation.
CONCLUSIONS: Sirtuin 2 enhances immediate early response 3 expression via deacetylation, inhibiting the solute carrier family 7 member 11-glutathione peroxidase 4 axis and promoting ferroptosis, thereby exacerbating acute pancreatitis. Serum sirtuin 2 and immediate early response 3 are potential biomarkers for acute pancreatitis severity. This study reveals a novel sirtuin 2-immediate early response 3-mediated mechanism driving ferroptosis in acute pancreatitis.
METHODS: Rats were pretreated with AGK2 a (sirtuin 2 inhibitor), Ferrostatin-1 (ferroptosis inhibitor), 1α,25-dihydroxyvitamin D3 (an immediate early response 3 inhibitor), adeno-associated virus-sirtuin 2, or adeno-associated virus-short hairpin-sirtuin 2 before L-arginine-induced acute pancreatitis. RNA sequencing was performed to identify potential downstream targets of sirtuin 2. In vitro, sirtuin 2 and immediate early response 3 expression was manipulated by small interfering RNA or overexpression plasmids. The effects on ferroptosis and inflammation were assessed using Western blot, quantitative polymerase chain reaction, immunofluorescence, and assays measuring reactive oxygen species, iron (II), mitochondrial membrane potential, and lipid peroxidation. Regulatory mechanisms among sirtuin 2, immediate early response 3, and ferroptosis were further investigated using co-immunoprecipitation and dual-luciferase assays.
RESULTS: AGK2 or ferrostatin-1 alone reduced pancreatic damage, inflammation, and ferroptosis, with combination therapy showing synergy. Sirtuin 2 or immediate early response 3 inhibition was protective, upregulating solute carrier family 7 member 11-glutathione peroxidase 4, reducing reactive oxygen species, iron (II), and lipid peroxides, and restoring mitochondrial function. Conversely, overexpression of sirtuin 2 or immediate early response 3 produced the opposite effects. AGK2 and 1α,25-dihydroxyvitamin D3 reversed damage from sirtuin 2 overexpression. Co-immunoprecipitation confirmed sirtuin 2 deacetylates and upregulates immediate early response 3. Luciferase assays showed immediate early response 3 transcriptionally represses solute carrier family 7 member 11. Clinically, serum sirtuin 2 and immediate early response 3 were elevated in patients with acute pancreatitis and correlated with disease severity and inflammation.
CONCLUSIONS: Sirtuin 2 enhances immediate early response 3 expression via deacetylation, inhibiting the solute carrier family 7 member 11-glutathione peroxidase 4 axis and promoting ferroptosis, thereby exacerbating acute pancreatitis. Serum sirtuin 2 and immediate early response 3 are potential biomarkers for acute pancreatitis severity. This study reveals a novel sirtuin 2-immediate early response 3-mediated mechanism driving ferroptosis in acute pancreatitis.